These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23099993)

  • 1. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.
    Zeller T; Muenstedt K; Stoll C; Schweder J; Senf B; Ruckhaeberle E; Becker S; Serve H; Huebner J
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):357-65. PubMed ID: 23099993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer.
    Yildirim Y; Tinar S; Yorgun S; Toz E; Kaya B; Sonmez S; Balsak D
    Eur J Gynaecol Oncol; 2006; 27(1):81-5. PubMed ID: 16550977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
    Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations.
    Helpman L; Ferguson SE; Mackean M; Rana A; Le L; Atkinson MA; Rogerson A; Mackay H
    Int J Gynecol Cancer; 2011 Apr; 21(3):587-93. PubMed ID: 21436708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
    Loquai C; Dechent D; Garzarolli M; Kaatz M; Kaehler KC; Kurschat P; Meiss F; Stein A; Nashan D; Micke O; Muecke R; Muenstedt K; Stoll C; Schmidtmann I; Huebner J
    Med Oncol; 2016 May; 33(5):52. PubMed ID: 27090799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
    Ben-Arye E; Schiff E; Steiner M; Keshet Y; Lavie O
    Int J Gynecol Cancer; 2012 Jan; 22(1):146-53. PubMed ID: 21912265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine use in patients with gynecological cancers in Europe.
    Molassiotis A; Browall M; Milovics L; Panteli V; Patiraki E; Fernandez-Ortega P
    Int J Gynecol Cancer; 2006; 16 Suppl 1():219-24. PubMed ID: 16515594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology.
    Drozdoff L; Klein E; Kalder M; Brambs C; Kiechle M; Paepke D
    Integr Cancer Ther; 2019; 18():1534735419846392. PubMed ID: 31046491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine in gynaecologic oncology.
    McKay DJ; Bentley JR; Grimshaw RN
    J Obstet Gynaecol Can; 2005 Jun; 27(6):562-8. PubMed ID: 16100633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center.
    Perlman A; Lontok O; Huhmann M; Parrott JS; Simmons LA; Patrick-Miller L
    J Oncol Pract; 2013 Jan; 9(1):34-41. PubMed ID: 23633969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.
    Abdallah R; Xiong Y; Lancaster JM; Judson PL
    Int J Gynecol Cancer; 2015 Nov; 25(9):1724-30. PubMed ID: 26397156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine among women with gynecologic cancers.
    Swisher EM; Cohn DE; Goff BA; Parham J; Herzog TJ; Rader JS; Mutch DG
    Gynecol Oncol; 2002 Mar; 84(3):363-7. PubMed ID: 11855870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center.
    Longhi A; Setola E; Ferrari C; Carretta E
    J Cancer Res Ther; 2021; 17(2):516-522. PubMed ID: 34121701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies.
    Fasching PA; Thiel F; Nicolaisen-Murmann K; Rauh C; Engel J; Lux MP; Beckmann MW; Bani MR
    Support Care Cancer; 2007 Nov; 15(11):1277-1284. PubMed ID: 17333294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
    Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
    J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.
    Richardson MA; Sanders T; Palmer JL; Greisinger A; Singletary SE
    J Clin Oncol; 2000 Jul; 18(13):2505-14. PubMed ID: 10893280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.
    Drozdoff L; Klein E; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Sep; 18(1):259. PubMed ID: 30249217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.
    Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E
    BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions from complementary and alternative medicine in patients with melanoma.
    Loquai C; Schmidtmann I; Garzarolli M; Kaatz M; Kähler KC; Kurschat P; Meiss F; Micke O; Muecke R; Muenstedt K; Nashan D; Stein A; Stoll C; Dechent D; Huebner J
    Melanoma Res; 2017 Jun; 27(3):238-242. PubMed ID: 28252553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.